Quality of anticoagulation control with acenocoumarol and the risk of cerebrovascular events

被引：0
|
作者：
Estevez-Fraga, C. [1 ]
Crespo-Araico, L. [1 ]
Agueero-Rabes, P. [1 ]
Molina-Sanchez, M. [1 ]
Alvarez-Velasco, R. [1 ]
Lopez-Martinez, M. J. [1 ]
Viedma-Guiard, E. [1 ]
Alonso-Canovas, A. [1 ]
De Felipe-Mimbrera, A. [1 ]
Masjuan-Vallejo, J. [1 ]
机构：
[1] Hosp Univ Ramon & Cajal, Neurol, Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF STROKE | 2015年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ESOC-0499
引用
收藏
页码：271 / 271
页数：1
相关论文
共 50 条
  • [1] QUALITY OF ANTICOAGULATION CONTROL WITH ACENOCOUMAROL AND THE RISK OF CEREBROVASCULAR EVENTS
    Estevez Fraga, C.
    Crespo Araico, L.
    Aguero Rabes, P.
    Molina, M.
    Alvarez Velasco, R.
    Lopez Martinez, M. J.
    Viedma Guiard, E.
    Alonso Canovas, A.
    Masjuan Vallejo, J.
    CEREBROVASCULAR DISEASES, 2015, 39 : 200 - 200
  • [2] Quality of chronic anticoagulation control with acenocoumarol and the risk of cerebrovascular events
    Estevez-Fraga, C.
    Crespo Araico, L.
    Agueero Rabes, P.
    Molina, M.
    Alvarez Velasco, R.
    Lopez Martinez, M. J.
    Viedma Guiard, E.
    Alonso Canovas, A.
    Masjuan Vallejo, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 803 - 803
  • [3] Bleeding risk factors in chronic oral anticoagulation with acenocoumarol
    Casais, P
    Luceros, AS
    Meschengieser, S
    Fondevila, C
    Santarelli, MT
    Lazzari, MA
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 63 (04) : 192 - 196
  • [4] Control of Anticoagulation With Warfarin or Acenocoumarol in Spain. Do They Differ?
    Barrios, Vivencio
    Escobar, Carlos
    Prieto, Luis
    Maria Lobos, Jose
    Polo, Jose
    Vargas, Diego
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (12): : 1181 - 1182
  • [5] Switching from acenocoumarol to warfarin in patients with unstable anticoagulation and its effect on anticoagulation control
    Undas, Anetta
    Ciesla-Dul, Mariola
    Zolcinski, Marek
    Tracz, Wieslawa
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (06): : 360 - 365
  • [6] INR variability in anticoagulation with acenocoumarol: is it useful for identifying patients at risk of bleeding and thrombosis?
    Casais, P
    Luceros, AS
    Meschengieser, S
    Bermejo, E
    Lazzari, MA
    HAEMATOLOGICA, 1999, 84 (08) : 753 - 754
  • [7] Anticoagulation with direct-acting anticoagulants decreases the risk of cardiovascular adverse events in patients with heart failure and atrial fibrillation compared to acenocoumarol
    Gonzalez Leal, A.
    Sanchez Vega, J. D.
    Antonana Ugalde, S.
    Arteagoitia Bolumburu, A.
    Alvarez-Garcia, J.
    Del Prado, S.
    Cordero, D.
    Jimenez-Blanco, M.
    Castillo, M.
    Gonzalez Ferrer, E.
    Zamorano, J. L.
    Alonso Salinas, G. L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 287 - 287
  • [8] HYPERTENSION, DIABETES AND THE RISK OF CEREBROVASCULAR EVENTS
    Li, Yao
    Wang, Jianli
    Xue, Hao
    JOURNAL OF HYPERTENSION, 2018, 36 : E272 - E273
  • [9] Tiotropium Use and the Risk of Cerebrovascular Events
    Haag, Mendel
    Verhamme, Katia
    Afonso, Ana
    Van Noord, Charlotte
    Koudstaal, Peter
    Sturkenboom, Miriam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S10 - S10
  • [10] Quality of anticoagulation using intravenous unfractionated heparin for cerebrovascular indications
    Fitzpatrick, Tess
    Wong, Courtney
    Shen, Cindy
    Pham, Peter
    Teo, Vincent
    Selby, Rita
    Geerts, William
    Khosravani, Houman
    THROMBOSIS RESEARCH, 2021, 199 : 79 - 81
12345